Form EFFECT Aspire Biopharma Holding
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 29, 2025 9:00 A.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seeker Price Prediction: SKR Jumps 29% as Remittix’s Crypto-to-Bank Model Draws Early-Move Buyers
- 4 Best Crypto Presales as Bitcoin Falls to $77.5K and Iran Tensions Hammer Altcoins
- Costa Rica Makes History as First Latin American Country to Launch English Learning as a National Initiative with Open English
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
